Drapkin Kimberlee C bought CLYM
June 5, 2026 · Form 4 insider transaction
Drapkin Kimberlee C bought 40,000 shares of Climb Bio Inc at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 3 days after the transaction.
Direction
Acquired (buy-side)
Shares
40,000
Price
$0.00
Total value
N/A
InsiderDrapkin Kimberlee C
RoleDirector
CompanyClimb Bio Inc (CLYM)
SecurityStock Option (Right to Buy)
Transaction codeA: Grant or award
Transaction dateJune 5, 2026
Filing dateJune 8, 2026
Shares owned after40,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The shares subject to the option will vest on the earlier of June 5, 2027 or the date immediately prior to the date of the next annual meeting of stockholders, subject to the reporting person's continued service through such date.